| | | | Western blot - MMP13 antibody (ab39021)  (enlarge) | |
| |
| Product Name | MMP13 antibody - Carboxyterminal end |
| | See all MMP13 antibodies (17)... |
| Product type | Primary antibodies |
| Description | Rabbit polyclonal to MMP13 - Carboxyterminal end |
| Immunogen | Synthetic peptide based on the carboxyterminal end of human MMP13. |
| Reacts with (species key) | Hu |
| Specificity | The antibody binds to MMP13, but does not cross react with the other MMP family members (MMP1, MMP2, MMP3, MMP9). We have a range of domain specific antibodies for this target. For a full list please see all MMP13 antibodies |
| Tested applications (see key) | WB |
|
| Abreviews | |
|
| Application notes (see key) | Recommended dilutions WB: Recommended starting dilution of 1/3000 (when using colorimetric substrates such as BCIP/NBT) and 1/6000 (for chemiluminescent substrates). Higher concentrations of antibody may be needed for non human samples. The antibody recognizes the latent proenzyme, at 60 kDa, as well as the active form at 48 kDa, and intermediate activation forms. When used against the reduced protein, the antibody identifies a band at 60 kDa (predicted molecular weight: 54 kDa). Notes: The low endogenous MMP13 protein levels may require concentration of samples by ultrafiltration or ammonium sulfate precipitation prior to Western blotting. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user. |
| Cellular localization | Secreted |
| Research areas | Cancer >> Tumor biomarkers >> Enzymes >> MMPs Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs Cancer >> Invasion/microenvironment >> Angiogenesis >> ECM enzymes >> MMPs Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP Cardiovascular >> Angiogenesis >> Adhesion / ECM >> Matrix Metalloproteinases >> MMP |
| Relevance | Collagenase 3 (MMP13) is a secreted 452 residue protein which is released from cells as aninactive zymogen and activated extracellularly by removal of its propeptide. MMP13 was first identified in tumor cells but has since been found in synoviocytes and normal fibroblasts stimulated by IL6 or a combination of TNF alpha and IL1. Under normal conditions, MMP13 is expressed during embryogenesis (fetal bone development) and is present only at very low levels in adult tissue. However, this enzyme is reported to be involved in the development and metastasis of breast and lung carcinomas, chondrosarcomas and osteosarcomas, head and neck carcinomas and some forms of skin cancer. Additionally, this enzyme plays an important role in degenerative bone diseases including osteoarthritis and rheumatoid arthritis. In rodents, MMP13 is thought to fill the role of MMP1, which they appear to lack. |
| | |
| Database links | The links below go to external sites and will open in a new browser window |
| Raised in | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purity | Immunogen affinity purified |
| Storage buffer | Preservative: Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
| Purification notes | The antibody has been peptide affinity purified. |
| Form | Liquid |
| Concentration | 1.000 mg/ml |
| Storage instructions | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles. |
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this MMP13 antibody - Carboxyterminal end is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| See below for MMP13 antibody - Carboxyterminal end images, references, products related to ab39021 and other tools. |
| |
MMP13 antibody - Carboxyterminal end images: |
Western blot - MMP13 antibody (ab39021) All lanes : MMP13 antibody - Carboxyterminal end (ab39021) at 1/3000 dilution
Lane 1 : Cell media from human chondrosarcoma (no treatment) Lane 2 : Cell media from human chondrosarcoma. (treated with IL1 beta).
Predicted band size : 54 kDa Observed band size : 60 kDa (why is the actual band size different from the predicted?) Additional bands at : 21 kDa,36 kDa. We are unsure as to the identity of these extra bands.
The antibody recognizes the latent proenzyme, at 60 kDa, as well as the active form at 48 kDa, and intermediate activation forms. When used against the reduced protein, the antibody identifies a band at 60 kDa. |
| |
| |
| Search PubMed (MEDLINE) for references to MMP13 |
| |
MMP13 antibody - Carboxyterminal end - more information |
Customer reviews (feedback) regarding MMP13 antibody - Carboxyterminal end |
Customer FAQs regarding MMP13 antibody - Carboxyterminal end |
Protocols for MMP13 antibody - Carboxyterminal end |
Price and availability of products related to MMP13 antibody - Carboxyterminal end |
| |
MMP13 antibody - Carboxyterminal end - related products: |
| |
| |
MMP13 antibody - Carboxyterminal end - other tools: |
Contact Abcam with a Technical Enquiry about MMP13 antibody - Carboxyterminal end |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"